tiprankstipranks
Trending News
More News >
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY)
:DRREDDY
India Market
Advertisement

Dr. Reddy's Laboratories Ltd. (DRREDDY) Price & Analysis

Compare
2 Followers

DRREDDY Stock Chart & Stats


Dr. Reddy's Laboratories Ltd. News

DRREDDY FAQ

What was Dr. Reddy's Laboratories Ltd.’s price range in the past 12 months?
Dr. Reddy's Laboratories Ltd. lowest stock price was ₹1025.90 and its highest was ₹1420.20 in the past 12 months.
    What is Dr. Reddy's Laboratories Ltd.’s market cap?
    Dr. Reddy's Laboratories Ltd.’s market cap is ₹1.02T.
      When is Dr. Reddy's Laboratories Ltd.’s upcoming earnings report date?
      Dr. Reddy's Laboratories Ltd.’s upcoming earnings report date is Oct 24, 2025 which is in 77 days.
        How were Dr. Reddy's Laboratories Ltd.’s earnings last quarter?
        Dr. Reddy's Laboratories Ltd. released its earnings results on Jul 23, 2025. The company reported ₹17.02 earnings per share for the quarter, missing the consensus estimate of ₹18.378 by -₹1.358.
          Is Dr. Reddy's Laboratories Ltd. overvalued?
          According to Wall Street analysts Dr. Reddy's Laboratories Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Dr. Reddy's Laboratories Ltd. pay dividends?
            Dr. Reddy's Laboratories Ltd. pays a Annually dividend of ₹8 which represents an annual dividend yield of 0.65%. See more information on Dr. Reddy's Laboratories Ltd. dividends here
              What is Dr. Reddy's Laboratories Ltd.’s EPS estimate?
              Dr. Reddy's Laboratories Ltd.’s EPS estimate is 17.59.
                How many shares outstanding does Dr. Reddy's Laboratories Ltd. have?
                Dr. Reddy's Laboratories Ltd. has 834,542,700 shares outstanding.
                  What happened to Dr. Reddy's Laboratories Ltd.’s price movement after its last earnings report?
                  Dr. Reddy's Laboratories Ltd. reported an EPS of ₹17.02 in its last earnings report, missing expectations of ₹18.378. Following the earnings report the stock price went up 0.576%.
                    Which hedge fund is a major shareholder of Dr. Reddy's Laboratories Ltd.?
                    Currently, no hedge funds are holding shares in IN:DRREDDY

                    Company Description

                    Dr. Reddy's Laboratories Ltd.

                    Dr. Reddy's Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, the company operates in the pharmaceutical sector and focuses on the development, manufacture, and marketing of a wide range of pharmaceutical products. Dr. Reddy's offers a diverse portfolio that includes generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and proprietary products. The company is committed to improving access to affordable medicines and operates in over 30 countries worldwide, with a robust presence in key markets like the United States, India, Russia, and Europe.

                    Dr. Reddy's Laboratories Ltd. (DRREDDY) Earnings & Revenues

                    DRREDDY Stock 12 Month Forecast

                    Average Price Target

                    ₹1,236.44
                    ▲(1.86% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"989":"₹989","1157":"₹1,157","1325":"₹1,325","1493":"₹1,493","1661":"₹1,661"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1660,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.66K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1236.44,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.24K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":990,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹990.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[989,1157,1325,1493,1661],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Dec<br/>2024","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1268.9,1298.9846153846154,1329.069230769231,1359.1538461538462,1389.2384615384617,1419.323076923077,1449.4076923076923,1479.4923076923078,1509.576923076923,1539.6615384615384,1569.746153846154,1599.8307692307692,1629.9153846153847,{"y":1660,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1268.9,1266.403076923077,1263.906153846154,1261.4092307692308,1258.9123076923079,1256.4153846153847,1253.9184615384615,1251.4215384615386,1248.9246153846154,1246.4276923076923,1243.9307692307693,1241.4338461538462,1238.9369230769232,{"y":1236.44,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1268.9,1247.446153846154,1225.9923076923078,1204.5384615384617,1183.0846153846155,1161.6307692307694,1140.1769230769232,1118.7230769230769,1097.2692307692307,1075.8153846153846,1054.3615384615384,1032.9076923076923,1011.4538461538461,{"y":990,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1254.86,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1370.17,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1365.41,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1340.89,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1266.22,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1213.75,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1213.75,"date":1733011200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1360.87,"date":1735689600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1110.61,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1145.14,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1175.54,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1241.23,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1268.9,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Aurobindo Pharma Ltd
                    Cipla Ltd
                    Lupin Limited
                    Torrent Pharmaceuticals Ltd
                    Zydus Lifesciences Limited
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis